Mosliciguat

DRUG3 trials

Sponsors

Pulmovant Inc., Pulmovant, Inc.

Conditions

Cardiovascular DiseasesFibrosisHealthy VolunteerInterstitial Lung DiseaseLung DiseasesPulmonary HypertensionPulmonary Hypertension Associated with Interstitial Lung DiseaseVascular Diseases

Phase 1

A Phase 1 Study of Mosliciguat in Healthy, Adult Males

Active, not recruitingNCT07185321

Pulmovant, Inc.Healthy Volunteer

Start: 2025-06-10End: 2026-05-31Updated: 2025-09-22

Phase 2

A Study of Mosliciguat in PH-ILD

Active, not recruitingNCT06635850

Pulmovant, Inc.Cardiovascular Diseases, Fibrosis, Interstitial Lung Disease +3

Start: 2024-10-29End: 2028-01-01Updated: 2026-02-20

A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

Active, not recruitingCTIS2024-513991-16-00

Pulmovant Inc.Pulmonary Hypertension Associated with Interstitial Lung Disease

Start: 2025-01-17Target: 96Updated: 2025-11-24